Clinical trial Recruiting at 1 site Observational Ages 18 to 55 Women only

Monitoring menopausal symptoms in women with gynecological cancer after ovary removal

Official title: An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy (Carnation1)

Run by Anhui Provincial Hospital · NCT06151028 · Data updated 2026-11-12

This study looks at how menopause symptoms and bone health change over time in women aged 18-55 with gynecological cancer who have had their ovaries removed, to find the best ways to help them feel better and prevent bone loss.

More Bone Loss trials

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexWomen only
Enrollment490 (estimated)
SponsorAnhui Provincial Hospital
Government
Drugs / interventionschemotherapy
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2033
Registry record updatedMarch 7, 2024
Trial IDNCT06151028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premenopausal women aged 18-55 with specific gynecological malignancies who have undergone surgery involving bilateral ovariectomy.

Probably not a fit

Patients who are already postmenopausal or have other concurrent tumors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on women aged 18-55 with gynecological malignancies who have undergone bilateral ovariectomy. It aims to monitor changes in menopausal symptoms and bone health over time, particularly the effects of platinum-based chemotherapy on these symptoms and bone loss. The study seeks to identify the optimal timing and effective regimens for menopausal hormone therapy in this unique patient population, providing guidance for osteoporosis screening and prevention strategies. By understanding these dynamics, the study aims to improve the quality of life for women facing early menopause due to cancer treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved management of menopausal symptoms and bone health in women with gynecological cancers.

How similar studies have gone: While there is ongoing research in managing menopausal symptoms in cancer patients, this specific approach focusing on gynecological malignancies and early menopause is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premenopausal women with gynecological malignancies aged 18-55 years old;

  * Tumor types include endometrial cancer, cervical cancer, epithelial ovarian cancer;

    * All patients received standard stage operation and treatment;

      * Patients with bilateral ovaries resection; ⑤Voluntarily participate in this study, willing to sign informed consent, and have long-term follow-up conditions.

Exclusion Criteria:

* Menopause (women over 40 years of age stop menstruation for 12 months, excluding pregnancy and other diseases that may cause amenorrhea can be clinically diagnosed as menopause); Or AMH \< 0.2ng/ml (China Menopause Management and Menopause Hormone Therapy Guidelines 2023 edition); Or FSH\> 40 mIU/ml after two checks within one month;

  * Other tumors were combined within 2 years and were still in radiotherapy, chemotherapy or hormone therapy;

    * Diagnosis of immunodeficiency disease or active hepatitis B, C, active tuberculosis; ④Serious organic diseases of the organs, etc., can not cooperate with the study follow-up; ⑤Long-term use of hormonal drugs for rheumatic system diseases, such as glucocorticoids;

      * Patients who have previously received pelvic or abdominal radiotherapy; ⑦ ECOG score ≥3 points; ⑧The patient did not sign informed consent or was unwilling to accept follow-up interviews.

Where it's running

  • Anhui Provincal Hospital
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.